LIFE SCIENCES | DAILY NEWS | OCT 07, 2025 | PHARMASHOTS
The post LIFE SCIENCES | DAILY NEWS | OCT 07, 2025 | PHARMASHOTS appeared first on PharmaShots.
Read article →
Arcutis Biotherapeutics Receives the US FDA’s Approval for Zoryve Topical Cream to Treat Atopic Dermatitis
Shots: Ref: Arcutis Biotherapeutics| Image: Arcutis Biotherapeutics| Press Release Related News:- The US FDA Approves…
Read article →
AbbVie Reports Topline P-II (ELATE) Trial Data on Botox (OnabotulinumtoxinA) for Upper Limb Essential Tremor
Shots: Ref: AbbVie | Image: AbbVie | Press Release Related News:- AbbVie Reports the US FDA’s BLA Submission of…
Read article →
AstraZeneca Reports P-III (Bax24) Trial Data on Baxdrostat for Treatment-Resistant Hypertension
Shots: Ref: AstraZeneca | Image: AstraZeneca | Press Release Related News:- AstraZeneca and Daiichi Sankyo Report…
Read article →
Daiichi Sankyo Reports the MHLW’s sNDA Submission of Enhertu + Perjeta to Treat HER2+ Breast Cancer
Shots: Ref: Daiichi Sankyo | Image: Daiichi Sankyo| Press Release Related News:- Daiichi Sankyo Reports the EMA’s MAA…
Read article →
Algen Biotechnologies Collaborates with AstraZeneca to Advance Drug Discovery in Immunology
Shots: Ref: BusinessWire | Image: AstraZeneca and Algen Biotechnologies | Press Release Related News:- Hinge Bio…
Read article →
Chiesi Group Enters a ~$2.1B Deal with Arbor Biotechnologies to Develop Novel Rare Disease Gene Editing Programs
Shots: Ref: Chiesi Group | Image: Chiesi Group and Arbor Biotechnologies | Press Release Related News:- Hinge Bio…
Read article →
Breaking New Ground in Oncology: Leonard Mazur from Citius Pharmaceuticals in Conversation with PharmaShots
Shots: Saurabh: What inspired your personal investment and commitment to Citius Pharmaceuticals’ mission in critical…
Read article →